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Background: Surveillance programs and research for acute respiratory infections in remote Australian communities
are complicated by difficulties in the storage and transport of frozen samples to urban laboratories for testing. This
study assessed the sensitivity of a simple method for transporting nasal swabs from a remote setting for bacterial
polymerase chain reaction (PCR) testing.
Methods: We sampled every individual who presented to a remote community clinic over a three week period in
August at a time of low influenza and no respiratory syncytial virus activity. Two anterior nasal swabs were collected
from each participant. The left nare specimen was mailed to the laboratory via routine postal services. The right
nare specimen was transported frozen. Testing for six bacterial species was undertaken using real-time PCR.
Results: One hundred and forty participants were enrolled who contributed 150 study visits and paired specimens
for testing. Respiratory illnesses accounted for 10% of the reasons for presentation. Bacteria were identified in 117
(78%) presentations for 110 (79.4%) individuals; Streptococcus pneumoniae and Haemophilus influenzae were the
most common (each identified in 58% of episodes). The overall sensitivity for any bacterium detected in mailed
specimens was 82.2% (95% CI 73.6, 88.1) compared to 94.8% (95% CI 89.4, 98.1) for frozen specimens. The sensitivity
of the two methods varied by species identified.
Conclusion: The mailing of unfrozen nasal specimens from remote communities appears to influence the utility of
the specimen for bacterial studies, with a loss in sensitivity for the detection of any species overall. Further studies
are needed to confirm our finding and to investigate the possible mechanisms of effect.
Clinical trial registration: Australia and New Zealand Clinical Trials Registry Number: ACTRN12609001006235.
Keywords: Respiratory bacteria, RT-PCR, Specimen transport, Laboratory methodsBackground
The rates of acute and chronic infections of the upper
and lower respiratory tract in Indigenous children in re-
mote communities in Australia are amongst the highest
reported worldwide [1,2]. Furthermore, repeated infec-
tions in childhood are thought to contribute to the high
rates of chronic lung disease in both adolescents and
adults in these communities [3].
Despite the excess burden of disease, with the exception
of ear disease, [4,5] there are no studies that have addressed* Correspondence: k.ogrady@uq.edu.au
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reproduction in any medium, provided the orthe aetiology and epidemiology of non-hospitalised re-
spiratory symptoms and acute respiratory illnesses in
both adults and children at the community level in re-
mote areas. One of the major impediments to this work
has been the limited capacity for the collection, hand-
ling, and transport of respiratory specimens. There is a
critical need for studies to both better understand re-
spiratory disease epidemiology and to evaluate the effi-
cacy of interventions, such as vaccines.
We undertook a study to assess the sensitivity of a
simple, cost-efficient method for transporting nasal
swabs from a remote setting for viral and bacterial real-
time PCR compared with transport using frozen speci-
mens. Our primary hypothesis was that there was nol Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tween mailed and frozen discordant pairs. We have pre-
viously reported our findings with respect to viruses [6].
Here we report the findings of the bacterial component
of the study.
Methods
The study was conducted in a remote desert community
in Central Australia over a period of three weeks from
late August to mid-September 2009. The community is
approximately 5 hours drive from the nearest regional
centre, predominantly via unsealed, rough roads. It has
an estimated resident population of 580, although this
fluctuates throughout the year. Daily presentation at the
community clinic ranges from 20 to 50 people. Data
from our viral studies indicated low influenza and no
RSV activity [6].
Study participants
We convenience sampled any person presenting to the
local health clinic who had spent the majority of the pre-
vious 14 days in the community. Individuals could either
be presenting with a medical complaint, visiting, or ac-
companying a friend or family member. Individuals
could participate in the study multiple times during the
course of the three weeks.
Data collection
We collected basic demographic and clinical data from
enrolled subjects including: Indigenous status, reason for
presentation at the clinic, clinic diagnosis for those seen
by clinic staff, current respiratory and general symptoms,
medications taken within the previous 7 days, and vac-
cination history.
Clinical specimens
Sample collection and viral testing are previously de-
scribed [6]. Briefly, two anterior nose swabs (from the
nasal vestibule just inside the nares), one from each nos-
tril, were collected using the Virocult collection system
(MW950, Medical Wire & Equipment, England). Swabs
taken from the left nostril were stored in the clinic re-
frigerator prior to being transported by normal post (air
transport) at ambient temperature from the community
once a week as exempt human specimens in accordance
with Australia Post’s Dangerous and Prohibited Goods
and Packaging requirements [7]. The right nare swab spe-
cimen was stored immediately at −20°C in a portable
freezer. At the end of the data collection period, they were
transported in that freezer to the Menzies School of
Health Research laboratory in Darwin, Northern Territory
and stored at −80°C. Frozen swabs were subsequently
transported overnight to the Queensland Paediatric Infec-
tious Diseases Laboratory in Brisbane, Queensland, in adry ice shipper (with continuous electronic temperature
monitoring) where they were again stored at −80°C until
analysis occurred. At the laboratory, prior to extraction,
2 ml of VTM was added to the swab transport tube and
thoroughly mixed by a vortex. Each sample was extracted
using the Qiagen X-tractor Gene instrument (Qiagen,
Australia) and the Qiagen DX reagents kit (Qiagen) ac-
cording to manufacturer’s instructions.
Specimen extracts were tested by real-time PCR for the
presence of Bordetella pertussis, Haemophilus influenzae,
Moraxella catarrhalis, Streptococcus pneumoniae, Staphylo-
coccus aureus, and methicillin-resistant Staphylococcus
aureus (MRSA). Standardised reaction mix and cycling
conditions were used; each reaction mix consisted of
12.5 μl of QuantiTect Probe PCR Master Mix, (QIAGEN,
Doncaster, Australia); 10.0 pmol of forward and reverse
primers (Table 1), 4.0 pmol of probe (Table 1) and 5.0 μl of
sample nucleic acid extract in a final reaction volume of
25.0 μl. Reactions were cycled on an ABI7500 real-time
PCR instrument (Applied Biosystems, USA) with the fol-
lowing parameters: initial hold at 95°C for 15 min followed
by 45 cycles at 95°C for 15 seconds and 60°C for 60 seconds.
Results were analysed using amplification plot data and
were considered positive if amplification curves crossed
above background fluorescence. Given previously described
specificity problems associated with H. influenzae PCR
methods; [8] specimens needed to be positive by two H.
influenzae PCR targets (hpd3 and p6; Table 1) to be consid-
ered positive for H. influenzae. MRSA was differentiated
from S. aureus as described by Renwick et al. [9]. As previ-
ously described, we assessed the quality of specimen collec-
tion by evaluating the presence of marker of human
genomic DNA, ERV3 [6].
Data analysis
We performed descriptive analyses of demographic and
clinical data, which are presented as proportions of all
participants or all paired specimens collected. Given the
sensitivity and specificity of real-time PCR diagnosis, we
considered a specimen from either nostril positive for
any bacterial species to represent a true-positive. This
approach means that the specificity of either specimen
type for any bacterial species will be, by definition, 100%.
Using this standard, we calculated sensitivity overall and
by specific species with 95% confidence intervals (CIs).
Binomial probability was used to test our primary hy-
pothesis of no difference in the likelihood of bacterial
species detection in either the mailed or frozen sample
for discordant specimens, with α = 0.05 (two-sided test).
Cycle threshold (Ct) values (cycle number at the
threshold level of log-based fluorescence) are a semi-
quantitative marker of, and are indirectly proportional
to, nucleic acid load. A 3.3 cycle difference represents
approximately a one-log difference in nucleic acid load
Table 1 List of primers and probes used in the study
Bacteria Designation Oligonucleotide sequence Gene Reference
Streptococcus pneumoniae F primer AGCGATAGCTTTCTCCAAGTG ply [10]
R primer CTTAGCCAAATCGTTTACCG
Probe FAM*-ACCCCAGCAATTCAAGTGTTCGCG- BHQ1§
Moraxella catarrhalis F primer GTGAGTGCCGCTTTTACAA copB [11]
R primer CCGTGAGTGCCGCTTTTACAACC
Probe FAM –TGCTTTTGCAGCTGTTAGCCAGCCTAA- BHQ1
Haemophilus influenzae F primer GGTTAAATATGCCGATGGTGTTG hpd3 [12]
R primer TGCATCTTTACGCACGGTGTA
Probe
Haemophilus influenza F primer CCAGCTGCTAAAGTATTAGTAGAAG p6 [13]
R primer TTCACCGTAAGATACTGTGCC
Probe FAM- CAGATGCAGTTGAAGGTTATTTAG–BHQ1
Staphylococcus aureus Staphylococcus aureus GTTGCTTAGTGTTAACTTTAGTTGTA nuc [14]
Staphylococcus aureus AATGTCGCAGGTTCTTTATGTAATTT
Probe FAM- AAGTCTAAGTAGCTCAGCAAATGCA–BHQ1
MRSAŦ mec2-F mec2-F SCCmec [9]
mec3-F ATTTCATATATGTAATTCCTCCACATCTC
mec4-F CAAATATTATCTCGTAATTTACCTTGTTC
mec5-F CTCTGCTTTATATTATAAAATTACGGCTG
mec7-F CACTTTTTATTCTTCAAAGATTTGAGC
orfX-R GGATCAAACGGCCTGCACA
Probe FAM-CRTAGTTACTRCGTTGTAAGACGTC-BHQ1
Bordetella pertussis F primer ATCAAGCACCGCTTTACCC IS 481 [15]
R primer TTGGGAGTTCTGGTAGGTGTG
Probe FAM- AATGGCAAGGCCGAACGCTTCA–BHQ1
*FAM = 6-Carboxyfluorescein §BHQ1 = Black Hole Quencher-1 ŦMRSA =Methicillin resistant S. aureus.
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40 for individual species were considered positive. To in-
vestigate the influence of low DNA loads on the discord-
ant results observed between the paired samples, we
reanalysed the data by excluding low DNA loads. For
this analysis, samples providing cycle threshold values of
36 cycles or above in the real-time PCR were deemed to
contain low DNA loads and were reassigned as negative.
All data were analysed using Stata 11 for Windows
(Stata Corp, College Station, TX).
Ethical conduct
We obtained signed informed consent from adult partici-
pants, assent from 10 to 18 year olds, and parent or guard-
ian consent for children up to 18 years of age. The project
was approved by the Central Australia Health Research
Ethics Committee, which includes an Indigenous research
ethics subcommittee, and by the Board of the region’s
Aboriginal Community Controlled Health Service.Results
Over the three weeks of the study, we recruited 140 par-
ticipants (82% of those screened) who contributed 153
study visits. Three study visits were excluded from fur-
ther analysis due to inadequate specimen identification,
leaving 150 paired specimens for analysis. There were no
temperature deviations during storage of frozen speci-
mens (maximum temperature −5°C) and the range for
mailed specimens during transport was 12.8 to 30.5°C.
Eighty-two percent of the participants were Aboriginal,
with the remainder being Caucasian, 60% were female
and 21% were aged less than five years. Eight individuals
were seen twice and three were seen three times. The
reason for presentation at the clinic was for an acute
upper respiratory illness in 10 (6.7%) visits, acute lower
respiratory illness in 3 (2.0%) visits, chronic respiratory
illness in 2 visits (1.4%), other medical conditions in 43
(28.7%) and visiting or accompanying another person in
92 (61.3%) visits [6].
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presentations for 110 (79.4%) individuals. In the 117 epi-
sodes where any bacterial species was identified, 23 had
only one species identified (19.6%), 28 (23.9%) had two
species, and 66 (56.4%) had three or more species de-
tected. There were 64 (54.7%) specimen pairs that were
discordant for at least one species; 18 were positive only
in the mailed specimen and 46 were positive only in the
frozen specimen (p = 0.006). There was concordance be-
tween paired specimens for at least one species in 90 ep-
isodes (76.9%); amongst these there were 39 (42.4%)
episodes in which discordance between specimen pairs
for a different species was also present. The overall sensi-
tivity for any species detected in mailed specimens was
82.2% (95%CI 73.6, 88.1) compared to 94.8% (95%CI 89.4,
98.1) for frozen specimens (Table 2). The sensitivity of the
two methods varied by species identified (Table 2).
ERV3 Ct values were higher (lower nucleic acid load)
in mailed specimens (mean: 33.1, 95% CI 33.0, 33.2)
compared to frozen specimens (mean: 31.5, 95%CI 31.4,
31.6); absolute difference 1.6 (95% CI 1.5, 1.7). The mean
ERV3 Ct value in episodes that were bacteria positive in
the left nare only was 32.5 (95% CI 29.2, 35.8) and the
mean for episodes that were positive in the right nare
only was 31.8 (95% CI 30.5, 33.2); absolute difference 0.7
(95% CI -4.5, 1.5).
After excluding specimens with low DNA loads, a sig-
nificant improvement (p < 0.0001) was observed in paired
sample result concordance, with 97 sample pairs proving
concordant. As might be expected, the overall number of
episodes that were positive for any species declined; there
was only marginal improvement in sensitivity for mailed
specimens (Table 2) and, conversely, a decline in sensitiv-
ity for S. aureus.
Discussion
Studies aimed at investigating respiratory illness and the
microbiology of those illnesses in remote communities
have to date been limited by the inability to store and
transport clinical specimens requiring freezing/refriger-
ation to urban laboratories. Our study has demonstrated
that freezing of specimens for viral studies at the time of
collection is not required, [6] however the detection of
common respiratory bacteria is affected, with lower de-
tection rates in mailed specimens.
The reasons for our findings are not clear, particularly
given similar divergence was not identified for viruses
[6]. Overall, it is evident that there is at least a moderate
loss in respiratory bacteria PCR sensitivity using the
mailed samples compared to those that were transported
frozen. This is further supported by the fact that the hu-
man DNA concentrations in the mailed samples were
significantly lower (as indicated by ERV3 PCR) in the
mailed samples, suggesting some DNA loss, possibly bydegradation, in the posted samples. However, the
amount of DNA loss that was observed (ie. to increase
ERV3 Ct values by 1.6 cycles) cannot fully explain the
lack of concordance between the paired samples, par-
ticularly the fact that some individuals had a very high
load of a particular bacterial species in one nostril, but
were negative for the same species in the other nostril.
Focal bacterial colonies may be present in specific indi-
viduals but these would be expected to be randomly dis-
tributed between the left and right nostrils in the
population as a whole. Furthermore for focal colonies to
be a plausible explanation for our finding of higher sen-
sitivity in frozen swabs (right nare swabs), this would
need to assume that bacteria were more likely to colon-
ise the right rather than the left nare. There are no data
to support this assumption and we are currently testing
this assumption by evaluating transport methods for
swabs from taken from the same nare. Alternatively,
given the overlap in confidence intervals for the sensitiv-
ities for each organism by transport method (Table 2),
our findings may be a factor of inadequate sample size
to compare differences in common respiratory bacteria.
We were unable to find similar studies in the literature
with which to compare our findings. Our study was
based on the assumption that there would be minimal, if
any, differences in presence and load of viral and bacter-
ial pathogens in the left and right nostrils of individuals,
and appeared valid on the basis of our findings with re-
spect to viruses. However, we now postulate that this is
not that case and that higher concordance between
transport methods may have been observed for the bac-
terial pathogens had two swabs from the same nostril
been used. As above, a further study is in progress to ad-
dress this issue.
Our findings need to be considered in light of the
feasibility and cost of respiratory pathogen surveillance
in remote areas where compromises in sensitivity may
be required in order for research to occur [17]. Overall
sensitivities for any bacteria detected were acceptable in
that context, particularly when the collection of speci-
mens for research purposes does not influence clinical
management decisions at the time the specimen was col-
lected. Furthermore, the ability to collect one specimen
per participant that can be readily shipped and analysed
for both viruses and bacteria is important given the in-
creasing emphasis on virus-bacteria interaction in acute
and chronic respiratory disease [18-21]. Ideally, nasal
swabs are best stored frozen within a short-time frame
at ultra low temperatures and shipping from a remote
community using nitrogen shippers or dry ice shippers
as the gold standard would be preferred. However, this
is not logistically feasible in these settings, particularly
when research staff are in the community for extended
periods, there are limited facilities to maintain dry ice
Table 2 Sensitivity for the detection of different bacteria according to specimen transport method and by cycle threshold cut-off value
Cycle threshold cut off ≤40 Cycle threshold cut off ≤36
Bacterium Mailed (Left nare) Frozen (Right nare) Mailed (Left nare) Frozen (Right nare)
Episodes +ve Sensitivity% 95%CI Sensitivity% 95% CI Episodes +ve Sensitivity% 95% CI Sensitivity% 95%CI
S. pneumoniae 87 78.2 68.0 – 86.3 97.7 92.0 – 99.7 72 84.7 74.3 – 92.1 93.1 84.5 – 97.7
H. influenzae 87 69.0 58.1 – 78.5 97.7 91.9 – 99.7 66 77.3 65.3 – 86.7 95.5 87.3 – 99.1
S. aureus 29 82.7 64.2 – 94.2 82.7 64.2 – 94.2 17 64.7 38.3 – 85.8 76.5 50.1 – 93.2
MRSA 8 75 34.9 – 96.8 62.5 24.5 – 91.5 3 0 - 100 -
B. pertussis 3 66.7 9.4 – 99.2 33.3 0.8 – 90.6 0 - - - -
M. catarrhalis 77 80.5 69.9 – 88.7 97.4 90.3 – 99.7 63 82.5 70.9 – 90.9 93.7 84.5 – 98.2
Any species 117 82.2% 73.6, 88.1 94.8% 89.4, 98.1 96 85.4 76.7 – 91.7 93.8 86.9 – 97.7
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http://www.biomedcentral.com/1471-2334/13/543for these timespans and, air freight in and out of the
community only occurs once a week. Similarly, future
studies should consider the use of concurrent collection
from both nares to maximise sampling efficiency.
Our choice of storage media (Virocult, MW950, Med-
ical Wire & Equipment, England) was also based on lo-
gistics, cost and that bacterial culture would not be
performed. The medium does not need to be stored re-
frigerated or frozen prior to use, unlike media commonly
used for bacterial culture, and there is no risk of break-
age during transport, an important consideration if pos-
tal services are used. Furthermore, there is no reason to
believe that the media itself would affect PCR detection
of bacterial DNA as indicated by our high overall posi-
tivity rates that are consistent with other studies in this
population. It should also be noted that there have been
some reports of false-positive results using the pneumo-
coccal ply PCR used in this study, [22] and so the results
here may represent a slight overestimation of carriage.Conclusions
Our study suggests that combining standard clinic re-
frigeration and weekly surface mailing of specimens com-
bined with real-time PCR, is potentially useful for
respiratory research in remote locations. However, further
investigation of the difference in sensitivity detected be-
tween mailed and frozen specimens for common respira-
tory bacteria is warranted and currently planned. A
simple, cost efficient approach is required to help us better
understand the epidemiology of respiratory viruses and
bacteria in remote, disadvantaged populations, where re-
current infections and persistent carriage are predominant
causes of morbidity and mortality in children and may re-
sult in chronic respiratory disease.
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